Overview and Scope
Smart biopsy devices refer to intelligent instruments intended to increase the precision and efficiency of tissue samples during medical procedures. It has features like image guidance, real-time feedback, or robotic help to improve diagnostic capabilities and patient outcomes. It is used for diagnosing cancer and delivering therapeutic drugs.
Sizing and Forecast
The smart biopsy devices market size has grown strongly in recent years. It will grow from $2.73 billion in 2023 to $2.93 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increased cancer cases, demand for minimally invasive procedures, innovations in medical devices, improved diagnostic accuracy.
The smart biopsy devices market size is expected to see strong growth in the next few years. It will grow to $3.78 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to personalized medicine growth, advancements in imaging modalities, rise in biopsy for biomarker analysis, market entry of new players, enhanced data connectivity. Major trends in the forecast period include robot-assisted biopsies, ai-driven biopsy assistance, development of wireless biopsy tools, portable and handheld devices, real-time guidance systems.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report
Segmentation & Regional Insights
The smart biopsy devices market covered in this report is segmented –
1) By Product: Needle-Based Biopsy Instruments, Procedure trays, Localization Wires, Other Products
2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques
3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications
4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers
North America was the largest region in the smart biopsy devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12271&type=smp
Major Driver Impacting Market Growth
The rising cancer cases are expected to propel the growth of the smart biopsy devices market going forward. Cancer is a broad category of illnesses that can develop in nearly any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. The rising number of cancer cases increased the need for precise and focused tissue samples. This has sparked the creation and advancement of smart biopsy instruments with better molecular, imaging, and precision capabilities to aid diagnosis and treatment planning. For instance, in October 2022, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in 2021, 1.58 million new cancer cases were diagnosed in Australia, an increase from 1.54 million new cancer cases in 2020. Therefore, the rising cancer cases are driving the growth of the smart biopsy device market.
Key Industry Players
Major companies operating in the smart biopsy devices market report are Cardinal Health Inc, General Electric Company, Medtronic Plc, Danaher Corporation, Canon Medical Systems Corporation, Toshiba Corporation, Siemens Healthineers, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Hologic Inc., Cook Medical Inc., CONMED Corporation, Leica Biosystems, Argon Medical Devices Inc., Esaote SpA, SOMATEX Medical Technologies GmbH, Planmed Oy, TSK Laboratory Europe B.V., ZAMAR CARE, DTR Medical Ltd., INRAD Inc., Sterylab Srl, EndoMed Systems GmbH
The smart biopsy devices market report table of contents includes:
1. Executive Summary
2. Smart Biopsy Devices Market Characteristics
3. Smart Biopsy Devices Market Trends And Strategies
4. Smart Biopsy Devices Market – Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Smart Biopsy Devices Market Size and Growth
…
32. Global Smart Biopsy Devices Market Competitive Benchmarking
33. Global Smart Biopsy Devices Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Smart Biopsy Devices Market
35. Smart Biopsy Devices Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
